Skip to main content

and
  1. Article

    Open Access

    A multi-center international study to evaluate the safety, functional and oncological outcomes of irreversible electroporation for the ablation of prostate cancer

    Irreversible electroporation (IRE) is a novel technique to treat localized prostate cancer with the aim of achieving oncological control while reducing related side effects. We present the outcomes of localize...

    Kai Zhang, Phillip Stricker, Martin Löhr in Prostate Cancer and Prostatic Diseases (2024)

  2. No Access

    Article

    Bladder cancer

    Bladder cancer is a global health issue with sex differences in incidence and prognosis. Bladder cancer has distinct molecular subtypes with multiple pathogenic pathways depending on whether the disease is non...

    Lars Dyrskjøt, Donna E. Hansel, Jason A. Efstathiou in Nature Reviews Disease Primers (2023)

  3. Article

    Open Access

    Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer

    The HGF/MET pathway is involved in cell motility, angiogenesis, proliferation, and cancer invasion. We assessed the clinical utility of plasma HGF level as a prognostic biomarker in patients with MIBC.

    Satoshi Katayama, Victor M. Schuettfort in Journal of Cancer Research and Clinical On… (2022)

  4. Article

    Clinical outcomes of low-pressure pneumoperitoneum in minimally invasive urological surgery

    The adoption of minimally invasive laparoscopic techniques has revolutionised urological practice. This necessitates a pneumoperitoneum (PNP) and the impact the PNP pressure has on post-operative outcomes is u...

    Alexander West, John Hayes, Darryl Ethan Bernstein in Journal of Robotic Surgery (2022)

  5. No Access

    Article

    Current application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centers

    There is no consensus on which items of Enhanced Recovery After Surgery (ERAS) should and should not be implemented in radical cystectomy (RC). The aim of this study is to report current practices across Europ...

    Simone Albisinni, Marco Moschini, Ettore Di Trapani in World Journal of Urology (2022)

  6. No Access

    Article

    Risks of metabolic diseases and androgen deprivation therapy for prostate cancer in a Chinese population: a prospective multi-centre cohort study

    Androgen deprivation therapy (ADT) use in prostate cancer (PCa) has seen a rising trend. We are looking into the relationship between ADT and development of metabolic diseases in Chinese patients.

    Chris Wong, Peggy Chu, Jeremy Teoh, Peter Chiu in International Urology and Nephrology (2022)